Cori Gorman
Directeur Général chez BioXpress Therapeutics SA
Postes actifs de Cori Gorman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
BioXpress Therapeutics SA
 BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland. | Directeur Général | 01/07/2010 | - |
| Président | 01/07/2010 | - |
Historique de carrière de Cori Gorman
Anciens postes connus de Cori Gorman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Selexis SA
 Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Suisse | 3 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectorielle
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
BioXpress Therapeutics SA
BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland. | Health Technology |
- Bourse
- Insiders
- Cori Gorman
- Expérience
